2 results match your criteria: "Mayo Clinic (JJC[Affiliation]"
Bilateral Simultaneous Nonarteritic Anterior Ischemic Optic Neuropathy: Demographics, Risk Factors, and Visual Outcomes.
J Neuroophthalmol
March 2023
Department of Ophthalmology and Visual Sciences, Washington University School of Medicine (JEC, JS, BSW, GPVS), St. Louis, MO; Department of Ophthalmology, Dean McGee Eye Institute, Oklahoma University Health Science Center (APB, ATM), Oklahoma City, OK; Department of Ophthalmology and Visual Neurosciences, University of Minnesota (MSL, CMM), Minneapolis, MN; and Department of Ophthalmology and Neurology, Mayo Clinic (JJC, MTB), Rochester, MN.
Article Synopsis
- The study investigates simultaneous bilateral nonarteritic anterior ischemic optic neuropathy (sNAION), a rare condition compared to unilateral cases (uNAION), by analyzing clinical features and risk factors.* -
- A total of 76 eyes from 38 sNAION patients and 38 eyes from an equal number of uNAION patients were reviewed, focusing on demographics, treatments, and visual outcomes.* -
- Results showed no significant differences in most parameters between both groups, except for a smaller cup-to-disc ratio in sNAION patients at follow-up, indicating potentially similar underlying mechanisms.*
Do Myelin Oligodendrocyte Glycoprotein Antibodies Represent a Distinct Syndrome?
J Neuroophthalmol
September 2019
Mayo Clinic (JJC), Rochester, Minnesota; and Save Sight Institute (CLF), Faculty of Health and Medicine, The University of Sydney, Sydney, Australia.